Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An international team, led by Phaik Yeong Cheah, conducted an anonymous online survey from May-June 2020, asking 5,058 people in Thailand, Malaysia, United Kingdom, Italy and Slovenia to share their experiences. Anne Osterrieder and colleagues in the Centre for Tropical Medicine & Global Health (Nuffield Department of Medicine) report the unequal impacts of public health measures, and the prevalence of ‘fake news’.

Photo of a busy desk, with a laptop and a mask © Supa-at Asarath

During the first wave of the COVID-19 pandemic in 2020 our lives changed dramatically, as governments implemented various public health measures to curb the spread of the virus. But what were the impacts of those restrictions on different social groups, and how did people receive information about COVID-19?

Between May-June 2020, in the first wave of the pandemic, the mixed-methods SEBCOV study asked people in Thailand, Malaysia, UK, Italy and Slovenia to share their experiences. Over 5,000 respondents completed our anonymous online survey. Now published in BMJ Open, SEBCOV’s data showed that COVID-19 and public health measures affected people from different countries and social groups unequally.

Read the full story on the Centre for Tropical Medicine & Global Health website.

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.